Impact of a TDM-guided ECPA Program for Optimizing Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam-based Regimen
RecruitingOBSERVATIONAL
Enrollment
65
Participants
Timeline
Start Date
August 28, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
Conditions
Liver Transplant Infection
Trial Locations (1)
40138
RECRUITING
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna
All Listed Sponsors
lead
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OTHER
NCT06718517 - Impact of a TDM-guided ECPA Program for Optimizing Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam-based Regimen | Biotech Hunter | Biotech Hunter